5 days ago
In an interview with a rodent Stuart Ashman of Skinbiotherapeutics (SBTX) branded me a “prolific liar” without actually evidencing one single lie. Anyhow on the question of prolific liars…
55 days ago
Yesterday I flagged up that Amazing AI (AAI) was again planning an Investor Meet Presentation and suggested that anyone doing business with a scumbag who weaponized my mum’s suicide had no moral compass. Zak Mir may still be “liking” X posts by Amazing but it seems that other advisors and enablers are abandoning ship. Marc Downes you are my first hero of the day.
55 days ago
It seems that for the 3rd time in six weeks Amazing AI (AAI) is set to appear on the Investor Meet platform. I wonder how much Investor Meet is trousering for platforming Paul Mathieson who most of the City is rushing to cold shoulder. I called Investor and spoke to its CEO Marc Downes following it up with the email below. Downes seems to think that both Amazing and I have equally valid two sides to a story. He had not bothered to fund out why Guild had quit as advisor last week. Giving moral equivalence to a man who publicly weaponises the suicide of a woman and to the son of that woman is despicable but that is the position Downes seems to take. My email , copying in my lawyers, reads:
274 days ago
Yes, I still think that shares in Skinbiotherapeutics (SBTX) are cheap at 19p, that there will be three quarters of revenues from Croda booked in the year to June 30 2025 with two quarters fully paid. But I see that the shares are off a penny today because we know what is looming.
286 days ago
I am not normally one to praise Stuart Ashman the CEO and Manprick the grossly overpaid CFO at Skinbiotherapeutics (SBTX) but yesterday’s investor meet presentation and Q&A was a very good showing by them both, especially Ashman. There I have said it. My key takeaways are:
610 days ago
It was an hour of my time which I may look back on my deathbed and consider an hour wasted. I should say that, on balance, there was enough offered by Ashman to make me content to hold shares in Skinbiotherapeutics (SBTX) but there were also worrying matters not least the CEO telling a blatant lie.
